Centene Corporation (CNC) is a healthcare company based in Missouri that offers health insurance plans for low-income populations. They are set to release their fourth-quarter results, with analysts expecting a non-GAAP loss of $1.25 per share. For fiscal 2025, their EPS is expected to be $2, a 72.1% drop from 2024, but a 47% surge is forecast for fiscal 2026. CNC stock prices have fallen 27.3% over the past year, underperforming the S&P 500 and Health Care Select Sector SPDR Fund. Centene shares rose 4.2% after Barclays upgraded the stock to “Overweight” with a price target of $54, citing positive prospects in the ACA market.

Read more at Barchart: Centene Earnings Preview: What to Expect